137 related articles for article (PubMed ID: 9634125)
1. CD5 negative diffuse mantle cell lymphoma with splenomegaly and bone marrow involvement.
Bell ND; King JA; Kusyk C; Nelson BP; Sendelbach KM
South Med J; 1998 Jun; 91(6):584-7. PubMed ID: 9634125
[TBL] [Abstract][Full Text] [Related]
2. Leukemic phase of mantle cell lymphoma presenting as anemia: diagnosis by combining flow cytometry and cytomorphology.
Brink DS; Grosso LE; Dunphy CH
Arch Pathol Lab Med; 1998 Nov; 122(11):1018-22. PubMed ID: 9822132
[TBL] [Abstract][Full Text] [Related]
3. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
4. De novo CD5+ Burkitt lymphoma/leukemia.
Lin CW; O'Brien S; Faber J; Manshouri T; Romaguera J; Huh YO; Kantarjian H; Keating M; Albitar M
Am J Clin Pathol; 1999 Dec; 112(6):828-35. PubMed ID: 10587706
[TBL] [Abstract][Full Text] [Related]
5. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
[TBL] [Abstract][Full Text] [Related]
6. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma.
Kurtin PJ
Adv Anat Pathol; 1998 Nov; 5(6):376-98. PubMed ID: 10095879
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
9. Leukemic phase of mantle cell lymphoma, blastoid variant.
Singleton TP; Anderson MM; Ross CW; Schnitzer B
Am J Clin Pathol; 1999 Apr; 111(4):495-500. PubMed ID: 10191769
[TBL] [Abstract][Full Text] [Related]
10. The splenic form of mantle cell lymphoma.
Angelopoulou MK; Siakantariz MP; Vassilakopoulos TP; Kontopidou FN; Rassidakis GZ; Dimopoulou MN; Kittas C; Pangalis GA
Eur J Haematol; 2002 Jan; 68(1):12-21. PubMed ID: 11952817
[TBL] [Abstract][Full Text] [Related]
11. [Mantle cell lymphoma with marked lymphocytosis at the presentation and with discordant morphology between the lymph node and peripheral blood].
Isobe Y; Kawamata N; Sato N; Irie S; Kato A; Mori T; Hirano T; Oshimi K
Rinsho Ketsueki; 1998 Sep; 39(9):692-7. PubMed ID: 9796405
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome.
Molina TJ; Delmer A; Cymbalista F; Le Tourneau A; Perrot JY; Ramond S; Marie JP; Audouin J; Zittoun R; Diebold J
Virchows Arch; 2000 Dec; 437(6):591-8. PubMed ID: 11193469
[TBL] [Abstract][Full Text] [Related]
13. Splenic lymphoma with villous lymphocytes with CD5+, CD11c+ B-cell phenotype.
Miyawaki S; Machii T; Hirabayashi H; Sakura T; Shiozaki H; Yashiro K; Murakami H; Tsuchiya J; Kashiwabara K; Kitani T
Intern Med; 1993 Jun; 32(6):472-5. PubMed ID: 7694693
[TBL] [Abstract][Full Text] [Related]
14. Derivative (14)t(11;14)(q13;q32)t(11;14)(p11.2;p11.2): a novel unbalanced variant of the t(11;14)(q13;q32) translocation in mantle cell lymphoma.
Sathanoori M; Shekhter-Levin S; Marks SM; Swerdlow SH
Cancer Genet Cytogenet; 2007 Jan; 172(2):158-64. PubMed ID: 17213026
[TBL] [Abstract][Full Text] [Related]
15. A unique case of mantle cell lymphoma with an aberrant CD5-/CD10+ immunophenotype and typical morphology.
Sriganeshan V; Blom TR; Weissmann DJ
Arch Pathol Lab Med; 2008 Aug; 132(8):1346-9. PubMed ID: 18684040
[TBL] [Abstract][Full Text] [Related]
16. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination.
Elmahy H; Hawley I; Beard J
Int J Lab Hematol; 2007 Dec; 29(6):461-3. PubMed ID: 17988302
[TBL] [Abstract][Full Text] [Related]
17. CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse.
Ferry JA; Yang WI; Zukerberg LR; Wotherspoon AC; Arnold A; Harris NL
Am J Clin Pathol; 1996 Jan; 105(1):31-7. PubMed ID: 8561085
[TBL] [Abstract][Full Text] [Related]
18. Malignant lymphoplasmacytic lymphoma with prominent splenomegaly (primary lymphoma of the spleen).
Audouin J; Diebold J; Schvartz H; Le Tourneau A; Bernadou A; Zittoun R
J Pathol; 1988 May; 155(1):17-33. PubMed ID: 3379515
[TBL] [Abstract][Full Text] [Related]
19. A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma.
Cuneo A; Bardi A; Wlodarska I; Selleslag D; Roberti MG; Bigoni R; Cavazzini F; De Angeli C; Tammiso E; del Senno L; Cavazzini P; Hagemeijer A; Castoldi G
Leukemia; 2001 Aug; 15(8):1262-7. PubMed ID: 11480569
[TBL] [Abstract][Full Text] [Related]
20. Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases.
Wu CD; Jackson CL; Medeiros LJ
Am J Clin Pathol; 1996 Mar; 105(3):277-85. PubMed ID: 8602607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
